Athersys, Inc. Receives Orphan Drug D...

Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome

There are 2 comments on the BioSpace story from Jul 10, 2012, titled Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome. In it, BioSpace reports that:

Athersys, Inc. announced today that MultiStemA , Athersys' proprietary cell therapy, has been granted orphan drug designation by the U.S. Food and Drug Administration for the treatment of Hurler's Syndrome, also known as mucopolysaccharidosis type I or MPS-I. Hurler's Syndrome is a lysosomal storage disorder that affects approximately 1 of every ... (more)

Join the discussion below, or Read more at BioSpace.


Singapore, Singapore

#1 Jul 11, 2012
any idea when a partnership for this is happening??? Don;t wish to see another dilution exercise.

Singapore, Singapore

#2 Jul 17, 2012
I'm starting to loose patience at Athersys. Whenever there's slightest bit of positive news, this damn stock will go down and remain down.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Straight Black men sidelined in AIDS fight 9 hr ThatBlackGuy 9
News Nymox Says Drug for Enlarged Prostate Doesn't M... (Nov '14) Sep 25 James1961 3
News Pharmaceutical Greed Villain Martin Shkreli Wil... Sep 23 madoff zionism 1
News Hillary Clinton tweet crushes biotech stocks Sep 23 LeDuped 11
News 'Smart Drug' May Not Be Such A Smart Decision (Mar '09) Sep 22 forddenies 7
News Planned Parenthood seeks fed study of fetal tis... Sep 11 Brian_G 771
News Bristol Palin says abstinence best path for teens (May '09) Sep 9 swedenforever 2,636
More from around the web